http://www.zibb.com/all/theme/cq/Geron+Corporation Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Tue, 24 Nov 2009 09:16:55 GMTTue, 24 Nov 2009 09:16:55 GMT608831http://www.zibb.com/all/theme/cq/Geron+Corporation http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.tercica.com/content.php?content_id=62Together, they provide valuable advice to help Tercica meet challenges, capture opportunities, and sustain momentum as we plan for our company's future.http://www.tercica.com/content.php?content_id=62Geron Corporationhttp://www.quotelinks.com/companies/gern.htmlStock quotes, news and charts for Geron Corporation Quotes Simple Charts Stock News MSN Investor Thomson Investors Short Interest Yahoo Finance CBS Marketwatch BigCharts StockCharts.com Yahoo Lycos Investing Quicken Yahoo News Quote.com (Lycos) CNET news ZDNet Business Week Stock earnings,http://www.quotelinks.com/companies/gern.htmlGeron Corporationhttp://www.transgenomic.com/ir/Press.asp?year=2003The following historical press releases contain statements that reflected management's views and estimates of future economic circumstances, industry conditions, company performance and financial results applicable on the dates they were first issued.http://www.transgenomic.com/ir/Press.asp?year=2003Geron Corporationhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=48648BIO CEO & Investor Conference 2007 MENLO PARK, Calif.--(BUSINESS WIRE)--Feb. 9, 2007--Geron Corporation (Nasdaq:GERN) will present an update of the company's product development programs at 1:15 p.m. ET on Monday, Feb. 12, 2007, at the BIO CEO & Investor Conference in New York City.http://www.pharmacychoice.com/News/article.cfm?Article_ID=48648Geron Corporationhttp://www.bioexchange.com/news/news_page.cfm?id=16925GERN News announced today that it has been issued U.S.\r\nPatent No. 6,548,741, describing an improved method for cloning pigs.\r\nThe inventors include some of the original scientists at the\r\nRoslin Institute in Edinburgh, Scotland, who cloned Dolly the sheep.http://www.bioexchange.com/news/news_page.cfm?id=16925Geron Corporationhttp://www.chessfinancial.com/research/newspr.asp?ticker=GERNGeron Announces Direct Equity Issuance... Business Wire 12/14/2006 4:55:58 AM Geron Corporation (Nasdaq:GERN) today announced that it has entered into a definitive agreement to sell common stock to institutional investors at $8.00 per share, for gross proceeds of $40.0 million.http://www.chessfinancial.com/research/newspr.asp?ticker=GERNGeron Corporationhttp://www.newsrx.com/newsletters/Vaccine-Weekly/2007-11-14/421114200769VW.htmlFor the third quarter of 2007, the company reported a net loss of $12.8 million, or $(0.17) per share, compared to $8.1 million, or $(0.12) per share, for the comparable 2006 period. Net loss applicable to common stockholders for the first nine months of 2007 was $29.3 million, or $(0.http://www.newsrx.com/newsletters/Vaccine-Weekly/2007-11-14/421114200769VW.htmlGeron Corporationhttp://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=GERN:US&sid=ajO0YqZpapscMENLO PARK, Calif.--(BUSINESS WIRE)--May 11, 2007 Geron Corporation (Nasdaq: GERN) today announced that Thomas B. Okarma, Ph.D., M.D., president and chief executive officer, will present an update of the company's product development programs at 2:55 p.m. CEST (8:55 a.m.http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=GERN:US&sid=ajO0YqZpapscGeron Corporationhttp://www.chessfinancial.com/research/story.asp?storyid=4089583Geron Corporation (Nasdaq: GERN) will present an update of the company's product development programs at 1:30 p.m. EST on Wednesday, Nov. 29, 2006, at the Lazard Life Sciences Conference in New York City.http://www.chessfinancial.com/research/story.asp?storyid=4089583Geron Corporationhttp://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=GERN:US&sid=aZofPUlhrlPYMENLO PARK, Calif.--(BUSINESS WIRE)--May 07, 2007 Geron Corporation (Nasdaq:GERN) will be presenting an update of the company's product development programs on Tuesday, May 8, 2007, at the UBS Global Generic & Specialty Pharmaceuticals Conference at 9:00 a.m. Eastern Time in New York City.http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=GERN:US&sid=aZofPUlhrlPYGeron Corporation